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Diabetic Retinopathy (DR) is a major disease and is the first cause of blindness in United 
Kingdom. Only in England 4200 new cases appear every year and 1280 lead to blindness. DR is 
a result of diabetes mellitus disease, which affects the retina of the eye and specifically the vessel 
structure. The elevated levels of glucose cause a malfunction in the cell structure, which affect 
the vessel wall and in severe conditions lead to them break. Quite a lot of research has been 
carried out for detecting the different stages of DR, but very few and versatile research has been 
done for the detection of DR early before the appearance of any lesions. In this review we 
approach the topic from the functional side of the human eye and how hemodynamic factors, 
which are impaired by diabetes, affect the vascular structure.  
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A critical approach and an effort to 
summarize the previous studies, the methods 
that were used and the limitations that were 
adopted, are intended in this manuscript. 
Diverse and comprehensive research is being 
conducted in this field, both from clinicians 
and computer scientists that creates the need of 
a deep understanding of the mechanisms 
underneath the development of DR. This fact 
enhances the necessity for a comprehensive 
approach in the functional impairment and the 
retinal vasculature alterations during the 
development and progress of diabetes, until the 
first lesions appear in the retina. 
Since DR could be prevented with early 
diagnosis, it is useful to focus on finding and 
categorizing all these changes that are 
triggered by the progress of diabetes. In 
addition to the review of the past and current 
research, in this article will be attempted to 
approach possible future trends and describe 
some challenges that arise from the study of 
the changes in retina vessels during the 
progress of diabetes as well as how these 
changes are depicted in a color fundus image. 
 
Anatomy of the retina 
The vertebrate retina is composed by ten 
distinct layers, which are categorized from 
closest to farthest from the vitreous body [1]. 
The retina of the eye is a light-sensitive layer 
of tissue, which is found at the inner surface of 
the eye and enables the conversion of the 
incoming light into a neural signal so as to be 
further processed in the visual cortex of the 
brain. It remains the best-studied part of the 
human brain. It is easily accessible nowadays 
with many different methods 
(ophthalmoscope, fluorescein angiogram, OCT 
etc.) both from scientists and clinicians. Its 
importance is highlighted from the fact that, 
according to estimations, around 80% of all 
sensory information in humans originates from 
retina [2, 6-8].  
As described above, retina is a layered 
structure of neurons interconnected with 
synapses from which only the photoreceptors 
cells are light sensitive. There are two main 
types of photoreceptors: a) rods, which are 
responsible for black-and-white vision, mainly 
in dark light, and b) cones which make the eye 
perceive colour and support daytime vision.  A 
third one is also found which is a much more 
rare type of photoreceptor, the intrinsically 
photosensitive ganglion cell, which responds 
to light in the absence of all rod and cone 
photoreceptors. 
In humans the entire retina is 
approximately 24mm in diameter [8]. It 
contains 7 million cones and 75 to 150 million 
rods. An important part of the retina is the 
optic disc, which is often called the blind spot, 
since it has no photoreceptors. It is found at 
the optic papilla, a nasal zone where the optic-
nerve fibres leave the eye [4-6]. In the fundus 
image, figure 1, this can be found as the white 
oval area, extending in an area of 3mm2. 
Temporal to the optic disc we find the macula, 
a small and highly sensitive part of the retina 
responsible for detailed central vision. In the 
very centre of the macula we meet fovea, 
whose main function contain sharp central 
vision, necessary in humans for activities that 
require visual details. 
In section, the retina size is 
approximately 0.25mm in thickness, which 
varies with age [9]. It has three layers of nerve 
cells and two of synapses including the ribbon 
synapses. The connection between brain and 
retina is made via optic nerve, which carries 
the ganglion cell axons in the brain, and the 




Although DR is a very common 
complication of diabetes still many cases are 
observed at a late stage where visual acuity is 
impaired and irreversible damage has already 
occurred [10, 11].  
The prevalence of DR is found to 
increase with duration of diabetes. According 
to some very interesting results from the 
Australian Diabetes, Obesity and Lifestyle 
study in diabetic patients with less than 5 years 
in diabetic state, the prevalence of DR is less 
than 10%, but this number becomes more than 
50% in those patients having diabetes for 20 or 
more years [12, 13]. 
The main risk factors of DR remain 
hypertension and hyperglycaemia but the 
hyperlipidaemia should not be excluded as 
well [14]. A number of epidemiological 
studies have highlighted the importance of 
hyperglycaemia in DR in addition to two 
pivotal studies: a) UK- prospective Diabetes 
study in patients with type 2 diabetes [15] and 
b) the Diabetes Control and Complications 
Trial in patients with type 1 diabetes [16, 17]. 
At the UK-PDS study there is another 
interesting part, which shows that by 
controlling the blood pressure level, reduces 
the risk of retinopathy regardless of the 
glycaemic level [18].  
An important thing to keep in mind is 
that the isolated retinopathy signs (micro-
aneurysms, haemorrhages and cotton wool 
spots) are found to be more common now in 
subjects without diabetes and hypertension, in 
comparison with what had been previously 
believed [13]. 
At an early stage DR affects the 
endothelial cells and the structure of muscle 
cells and leads to the loss of pericytes [19]. 
The proliferation of the endothelial cells and 
the thickening of the membrane cause vascular 
occlusion, whereas pericyte loss is responsible 
for the formation of micro-aneurysms.  The 
big challenge remains to detect and understand 
the microvascular hemodynamic abnormalities 
in a stage that there are no morphological 
alterations in the retina. In this stage the 
clinicians could be able to intervene and 
prevent the progress of the disease still in a 
reversible stage. 
Unfortunately the pathogenesis of DR is 
not yet fully understood both in cellular and 
molecular level limiting the options for 
effective therapeutic interventions early, while 
the disease still develops [20, 21]. It remains to 
be fully understood the exact mechanism that 
triggers the formation of the microvascular 
lesions. 
In general, hyperglycaemia appears to be 
sufficient to initiate the development of DR as 
revealed by some experiments in animals, 
which were made hyperglycaemic in the lab 
[22-24]. At the same time similar studies have 
shown that by intensively and sufficiently 
controlling hyperglycaemia leads to the 
inhibition of the development of DR [25]. 
Possible geometric alterations in the 
retina might indicate the existence of a 
systemic disease. Functional changes can be 
depicted in the retina vasculature and also be 
measured using devices like flow velocity 
meters, oximeters etc. Assessing these 
functional and hemodynamic changes in a 
qualitative way might help to bypass the 
limitations of studying only the morphological 
features. Moreover it can help differentiate 
between diseases that their structural effect in 




The retinal circulation is directly 
observable and has its own blood supply, 
which comes from behind the eye and enters 
the retina through the optic nerve. It is an end 
arterial system without anastomoses. The 
central retinal artery brings the blood into the 
retina and the central retinal vein drains the 
blood out of the eye leading the blood back to 
the heart for re-oxygenation [26, 27].   
 
Screening of the retina 
Retina remains the only non-invasive 
way of viewing human vessels. Using proper 
techniques, retina is visible from the outside, 
which assists on the imaging of the retina and 
brain tissue non-invasively [28, 29]. Moreover, 
due to the fact that retina is a highly 
metabolically active tissue with a double blood 
supply, it allows direct non-invasive 
observation of the circulation [30, 31]. 
The reason why retina is so much 
studied remains the fact that both eye and 
other diseases that affect the circulation and 
the brain can be illustrated in the retina [32, 
33]. Macular degeneration and glaucoma are 
among the most prominent diseases and with 
DR the most important causes of blindness in 
the developed world [34]. 
In addition to the eye diseases, a number 
of systemic diseases also affect the retina. 
Complications of such diseases include 
diabetic retinopathy from diabetes mellitus, 
hypertension from cardiovascular disease and 
multiple sclerosis [35]. 
During the last decades, the advances in 
the non-invasive techniques that are used for 
measuring several features in the retina have 
led to the exploration of different aspects on 
the retinal hemodynamic, geometric features 
and blood flow regulation both in normal and 
diseased human eye. Some examples of these 
techniques are the following: The retinal 
vessel analyser (RVA) [36], dye dilution 
technique for arterio-venous passage time 
(AVP) [37], blue field simulation (BFS) for 
the velocity and the number of leukocytes 
[38], bidirectional laser Doppler velocimetry 
(LDV) for the red blood cell velocity [39], 
laser Doppler flowmetry for the blood flow in 
the tissue of the optic disc [40] and colour 
Doppler imaging for the central retinal arterial 
blood velocity [41]. Regarding the 
measurement of retinal blood flow another 
methodology includes the video fluorescein 
angiography, which relies on the rapid 
injection of a small bolus fluorescein dye and 
the recording of the retinal images with a 
scanning laser ophthalmoscope in order to 
distinguish the resultant vascular fluorescence 
from the passage of fluorescent dye through 
the retinal circulation [42]. 
 
Blood flow mechanisms in diabetes 
An impairment in retinal blood flow is 
one of the earliest abnormalities occurred in 
the human body in diabetes [43]. Only 4% of 
the blood flow delivered to the eye is 
distributed to the retina [44]. Impairment of 
retinal circulation results in blood flow 
alterations, which consequently affect the 
delivery of oxygen and metabolic substrates to 
the tissue. The maintenance of the function 
and structure of the retina is highly affected 
from these abnormalities [45].  
Grunwald et al. defined the problem of 
the importance or not of the blood flow 
especially in comparison with perfusion 
pressure [46]. In their initial study in diabetic 
patients they found that both the mean blood 
pressure and perfusion pressure in all of their 
patients who were normotensive, were 
significantly higher in those five patients 
whose blood flow did not decrease after 5 days 
and whose retinopathy deteriorated at 6 
months. Another observation shows that there 
is evidence that increased blood pressure is 
correlated with increased prevalence of 
retinopathy [47-49]. In the Wisconsin study 
was found that systolic blood pressure is a 
significant predictor of the incidence of 
diabetic retinopathy, while diastolic blood 
pressure can be an important predictor of the 
progression of the disease [48].  
Perfusion pressure can also be of 
importance in diabetic retinopathy early 
screening, since the normal auto-regulatory 
response mechanism of vessels is impaired. 
Perfusion pressure can be calculated by 
subtracting the intraocular pressure from the 
two-thirds of the mean arterial pressure [50]. 
In another study using light stimulation 
in patients with well controlled type 1 diabetes 
with no signs of retinopathy showed that the 
functional abnormalities consist of reduced or 
no dilation of retina vessels as well as reduced 
or no constriction of retinal arteries as a 
response to the increase of intraluminal 
pressure [51, 52]. Very interesting finding [53, 
54] was that flickering light stimulates and 
activates auto-regulatory mechanisms that 
dilate the retinal blood vessels and affect the 
blood flow by enhancing the circulation. In 
healthy subjects the response relates to the 
increase of the retina vessels by 2-4% whereas 
in diabetic patients there is slight or no 
response to the stimuli at all. An observation 
of the response of the retina vessels to 
increased intraluminal pressure and how the 
vascular mechanisms manage to regulate this, 
suggests that in normal arteries, an elevation in 
intraluminal pressure leads to the constriction 
of the vessels or to the dilation under pressure 
reduction. All of these occur by using the 
inherent mechanisms in the vascular smooth 
muscles that are independent of any hormonal, 
neural or metabolic influences. This 
mechanism is termed myogenic response [55].  
It can be inferred from the above studies, 
that blood flow is an important window for 
understanding and measuring the changes 
during the progress of the disease. Every 
single change either it is in the vessel structure 
or in the microcirculation directly affects the 
blood flow inside the vessels. It is a fact that 
most of the studies use different methods to 
take such measurements and different metric 
system. It still remains a very difficult task to 
associate changes in blood flow with the 
progress of a disease since many other factors 
might influence the blood flow, which have to 
be excluded in the first place. 
 
Biomarkers 
A few tests were run to evaluate the 
response of the retina vessel structure to 
different stimuli, measuring at the same time 
these changes in vascular diameter either with 
laser Doppler flowmetry or with the dynamic 
retina vessel analyser [55-58]. Besides the 
measurements that were taken in different 
segments, some retinal vascular calibre 
changes were identified and associated with 
early consequences of diabetes making them 
candidates to become biomarkers of risk for 
diabetic complications. 
A biomarker can be defined as a feature 
that is accurately and objectively measurable 
and is evaluated as an indicator of regular 
biological and pathogenic processes or 
responses in a specific drug treatment [59]. It 
is clear that some systemic markers like blood 
pressure, duration of diabetes, glucose level 
and lipid levels are definitely relevant factors, 
but on the other hand they cannot be used to 
identify the proliferation of DR [60]. It is 
observed that even patients under good 
glycaemic control can be worsen rapidly, in 
contrast to patients with poor control that 
might remain in stable condition [61]. This led 
to the identification of different phenotypes of 
progression taking into account the 
characteristics of the retinal lesions.  
An important thing in defining the 
rudimental value of a novel biomarker [62] is 
the statistical evaluation with common 
statistical methods like area under the curve 
(AUC) or C-statistic but also with novel 
methods such as weighted net reclassification 
index (WNRI) and/or net benefit (NB). Using 
standard statistics we can only obtain 
information for the overall improvement, 
differentiating over the whole range of 
possible decision thresholds. On the contrary, 
using more advanced techniques for decisions 
or analytic performance measurements like 
WNRI or NB we can obtain clinically useful 
results using a smaller range of thresholds with 
tested relevance in medical applications 
[49].Regarding diabetic retinopathy, until this 
review, there is no biomarker that satisfies the 
above criteria although research is conducted 
in several areas.  
Time of testing plays a crucial role in 
accurately and reliably measuring the 
hemodynamic features at fixed state. Diverse 
indications of the abnormalities in diabetic 
patients are observed, which are assumed to be 
attributed to the influence of blood glucose 
level during the testing [63, 64]. Applying 
some stimuli in the retina can cause abnormal 
auto-regulation of blood flow in diabetic 
retinopathy patients, with a simultaneous 
increase of the flow, in parallel with the 
proliferation of  DR [65]. 
Changes in the retinal architecture may 
result in impaired space filling and 
microcirculatory transport non-uniform shear 
distribution in branches and bifurcations. 
Moreover it might cause reduced energy 
efficiency in blood flow giving a strong 
indication of early disease state [62]. 
 
Pathology in diabetic retina 
The pathological processes during 
diabetes are initially subtle but affect the 
whole hemodynamic functionality of the 
retina. During normal state, the auto-regulation 
mechanisms keep the blood flow constant in 
all the range of systemic blood pressure and 
intraocular pressure [3, 66-68]. The vessel 
responses are regulated locally by targeting the 
smooth muscle cells in arterioles and capillary 
pericytes [68-70]. On the contrary, during 
diabetes, there are changes in local vasoactive 
factors and the response of pericytes to these 
factors is altered as well [71- 73]. 
Tight junction complex proteins help in 
the creation of the blood-retinal barrier. In 
order to maintain normal neural function, the 
tight junction is responsible for the connection 
of the endothelial cells in the brain and retina 
[74]. In some diseases like DR, the actions of 
the vascular endothelial growth factor (VEGF) 
and cytokines on the tight junction proteins 
affect the vascular permeability and cause 
changes in the blood retinal barrier. The 
importance of blood-retinal barrier (BRB) can 
be highlighted from the fact that it is 
responsible for the prevention of certain 
substance entering into the tissues of the 
retina. BRB is formed from tight-junctions 
between retinal epithelial cells and non-
fenestrated capillaries of the retinal circulation. 
According to emerging evidence, 
neurodegeneration has been found to occur 
early in the pathogenesis of DR. In addition to 
neural apoptosis some changes in glial cells 
(non-neurons) occur as well and the process is 
known as reactive gliosis. It is still unclear 
which of the two processes occurs first in the 
degeneration process. The most important 
mechanisms that mediate the 
neurodegeneration process are a) oxidative 
stress, b) extracellular glutamate accumulation 
and c) reduction of neuro-protective factors 
synthetized by the retina [75]. 
The term oxidative stress, as defined, 
describes the imbalance that occurs between 
the ROS and the antioxidant defenses of a 
living system [76]. Tissue damage and 
pathophysiology is triggered by oxidants like 
ROS and reactive nitrogen species (RNS). The 
oxidative stress, which is caused by 
hyperglycemia, is considered an important 
pathway of diabetic microvascular 
complications [77]. There is strong evidence 
that the correlation between hyperglycemia, 
redox homeostasis and oxidative stress is 
responsible for the pathogenesis of DR [78, 
79]. Another hypothesis supported that the 
oxidative species are responsible for the 
development and progression of DR [80]. 
Animal studies showed that oxidative species 
contribute to the resistance of retinopathy 
since they prevent proliferation after the good 
glycaemic control has been established [81]. 
Brownlee suggested that oxidative stress is 
very important since it links all the damaging 
biochemical pathways induced by 
hyperglycaemia in DR [82]. 
The Hoorn study reported the 
significance of subclinical inflammation to the 
development of DR [83]. DR is considered a 
low-grade inflammatory disease affecting the 
leukocytes’ rolling and adhesion [84]. 
Nowadays the role of inflammation has been 
enhanced and it is considered very important 
though complex and unclear. Inflammation is 
triggered by factors such as hyperglycaemia, 
oxidative stress, hypertension etc. but this 
creates a chain reaction since inflammation 
propagates these pathways further through 
cytokines, VEGF signalling, adhesion 
molecules, enhanced RAGE expression, Nitric 
oxide regulation and NF-kβ signaling. The 
subclinical inflammation via e-NOS leads to 
increased intraocular pressure [85]. 
 
Diabetes effect in vessel structure 
Hyperglycaemia leads to intramural 
pericyte death and thickening of the basement 
membrane, which contributes highly to the 
alterations in the integrity of the retinal blood 
vessels. This fact causes changes to the blood-
retinal barrier and vascular permeability [86, 
87].  
         During the hyperglycaemic state the 
endothelial cells align and elongate in the 
direction of shear stress modifying some of 
their functions at the same time. Shear stress is 
defined as the component of stress coplanar 
with a material cross section [88]. The 
endothelial cells respond to the increased shear 
stress and produce more a vasodilator named 
nitric oxide (NO), which causes the expansion 
of the blood vessels. This homeostatic reaction 
of the vessels occurs in order to restore the 
normal shear stress by decreasing the blood 
flow velocity [89, 90]. 
Another major issue is the development 
of atherosclerotic plaque, the hardening and 
thickening of arterial wall, due to the reactive 
oxygen species and inflammation. These two 
factors can be supressed by the nitric oxide. If 
the endothelial cells do not produce enough 
nitric oxide in response to shear stress in a 
diabetic state, can contribute to the 
development of atherosclerosis to diabetic 
patients [91].   
The pulsatile flow of the blood through 
the vessels activates the endothelial nitric 
oxide (ENO) [92]. The shear stress, which is 
caused from the blood pressure in every beat 
of the heart, makes the vessels stretch and 
relax since the column of blood inside the 
vessels has not steady flow. The role of the 
ENO is to maintain the diameter of the blood 
vessels so as to preserve the perfusion of 
tissues at optimal levels. Vascular endothelial 
growth factor mediates the release of NO from 
human umbilical venous endothelial cells [93, 
94]. 
        High sugar levels cause alterations to the 
structure of the proteins. The endothelial cells 
attach to the proteins that are placed 
underneath them. The collagen, which is 
important substance for the elasticity of the 
vessel wall, becomes glycated in the high 
blood sugar state [95]. This means that sugar 
attaches to one of the collagen amino acids and 
creates a chain reaction. When a cell attaches 
to a glycated collagen there is a change in how 
it responds to the blood flow. For instance, the 
cells do not align in the flow direction and they 
do not even release nitric oxide. The 
production of advanced glycation end products 
is increased by the increase of superoxide 
anion [91].  
         Metabolic abnormalities are a main 
characteristic of diabetes, which include 
hyperglycaemia, free fatty acids and insulin 
resistance. These three factors provoke 
molecular mechanisms, which in their turn 
alter the function and the structure of the 
vessels. Oxidative stress is one of those 
affected, in addition to the malfunction of the 
intracellular signal transduction [91, 96, 97]. 
One very important concept defines that 
hyperglycaemic-induced oxidative stress, very 
common in diabetic retinopathy, mediates 
endothelial malfunction in diabetic patients. 
This is proven by the observations that intra-
arterial infusion of ascorbic acid restores 
endothelium-dependent vasodilation in healthy 
subjects exposed to a hyperglycaemic clamp as 
well as in patients with type 1 and type 2 
diabetes [91, 98].  
Vascular muscle cell apoptosis in 
atherosclerotic lesions is also increased, in 
such a way that patients with diabetes are 
prone to having fewer smooth muscle cells in 
the lesions, which increases the tendency for 
plaque rupture. The signalling pathways in the 
cells are affected totally from the way that 
cells adhere to the substrate proteins. 
Moreover since the cells attach to the glycated 
collagen in a completely different way than 
normal collagen, leads to different way of 
responding to the mechanical forces. Although 
the high blood sugar state is more frequent, the 
cells response to blood flow is altered even in 
low blood sugar levels [91].  
The arterial wall is becoming stiffer with 
the aging but diseases like diabetes can 
accelerate this natural process. The arterial 
muscle cells contraction and relaxation are 
affected by the impaired endothelial cells 
which affect the wall stiffness by the 
modification of the isometric tone [99]. 
 
Hemodynamic changes in diabetes and DR 
– Experimental results in literature 
Burgansky et al. studied the effect of 
diabetic retinopathy to the blood flow velocity 
in 42 diabetic patients and 38 healthy subjects 
finding that the velocity was slower in DR 
patients than healthy subjects (3.74±1.09 for 
DR and 4.19±0.99 for healthy – p-value 
<0.001) [100, 101]. 
Moreover they investigated the early 
hemodynamic alterations in patients with 
diabetes before the first lesions appear to the 
retina. In this study the blood flow velocity in 
the retinal vasculature of adult-onset diabetic 
patients with no signs of diabetic retinopathy 
(23 eyes) was compared with that of age-
matched healthy subjects (51 eyes). For all the 
participants’ measurements of blood glucose 
level, glycosylated haemoglobin (HbA1C), 
body mass index, intraocular pressure, 
systemic blood pressure and heart rate were 
taken. According to their results, the blood 
flow velocity in arteries was 4.7±1.7 mm/sec 
in the diabetic group, which is significantly 
higher than that of the healthy group 
4.1±0.9mm/sec, with p-value=0.03. The 
velocity in venous in both groups was slower 
than arteries (3.8±1.2 mm/sec in DM group 
and 2.9 mm/sec in healthy group with p-
value<0.0001). It is worth mentioning that in 
the diabetic group, the velocity values in both 
arteries and veins were not correlated to the 
duration of diabetes, the level of glucose, 
HbA1C or BMI [68, 101].  
It is apparent that the increased velocity in 
diabetic patients compared to healthy subjects 
is opposed to the findings in DR patients [88]. 
That means that the relationship between the 
patient and healthy blood flow velocity 
reverses during the development of 
morphological alterations in the retina, as 
arteries reach their limits and capillary 
resistance defines the flow volume. In two 
studies [102,103] was found that blood flow 
velocity decreases over time in some but not 
all diabetic patients. 
Takahiko et al. assessed the blood flow 
in the bilateral central arteries in 50 insulin-
dependent diabetic patients without any signs 
of DR and they used 20 sex-and-age matched 
normal subjects as a comparison. For the 
measurements they used Duplex Doppler 
sonography [104]. The parameters that they 
measured were peak-systolic velocity (PSV), 
end-diastolic velocity (EDV), time averaged 
velocity (TAV), resistance index (RI) and 
pulsatility index (PI). As was expected the 
results were different between diabetic patients 
and normal subjects. PSV, EDV and TAV 
were lower in diabetic patients (9.9±1.9, 
3.2±0.9 and 5.1±1.1 cm/s respectively) than in 
normal subjects (11.1±1.4, 3.9±0.7 and 
6.0±1.0 cm/s respectively) with p-value<0.05, 
p-value<0.01 and p-value<0.01 respectively. 
Regarding the RI index it appeared to be 
higher in diabetic patients (0.70±0.05) than in 
normal subjects (0.65±0.05) with p-
value<0.01. Finally for PI there was no 
significant difference between diabetic patients 
and normal subjects (1.37±0.45 vs. 1.22±0.30). 
Another interesting finding is that RI is 
correlated with the levels of glucose (r=0.310, 
p-value=0.0248) but not with haemoglobin 
levels (r=0.184, p-value=0.202), blood 
pressure or duration of diabetes. The outcome 
shows that retinal artery blood flow velocities 
were decreased whereas vascular resistance 
was increased in diabetic patients without 
clinical signs of DR. 
Grunwald et al. recruited 19 diabetic 
patients with less than 4 years of diabetes and 
16 age-matched normal subjects. In their 
experiment they measured different venous 
segments according to the quality of the 
images with a mean value of 4.4 and 4.5 in 
diabetic patients and normal subjects 
respectively. Haemodynamic parameters like 
blood glucose, mean blood pressure, 
intraocular pressure, perfusion pressure, 
haemoglobin and duration of diabetes were 
taken into account. The total measured blood 
flow rate in the diabetic patients was 
43.3(standard deviation (SD) 8.9) µl/min, 
which is significantly higher than normal 
subjects (38.5(SD 4.7) µl/min) by about 12% 
(p-value<0.05) [105].  A positive correlation 
was also observed between blood flow and 
disease duration.  
The total venous cross-section was 
93.5(SD 20.3) cm2x10-5 in diabetic patients, 
much higher than that of normal subjects 
(83.6(SD14) cm2x10-5) by about 12% with p-
value<0.05. Again a correlation was observed 
between the total venous cross-section and 
duration of diabetes (r=0.34, p-value<0.05). 
Regarding the blood flow velocity in the 
largest retinal vein in both eyes appeared not 
to be significantly different between normal 
subjects and diabetic patients (1.79(SD 0.22) 
cm/s and 1.72(SD 0.39) cm/s respectively) and 
no significant correlation was observed 
between the velocity and duration of the 
disease(r=0.05, p-value<0.1). A very 
interesting part of this experiment was the 
measurement of the retinal vascular regulatory 
response in hypoxia which was defined as the 
percentage decrease in blood flow rate, blood 
flow velocity and large venous diameter 
between normal room air breathing and 100% 
oxygen breathing provided externally. This 
magnitude was found to be -11.6%(SD 4.5%) 
for venous diameter, -35.2%(SD 8.4%) in 
blood flow velocity and -49.2%(SD 7.8%) in 
blood flow rate but showing no significant 
difference from those of the normal subjects (-
12.6%(SD 4.1%), -38.2(SD 10%) and -
53%(SD 8.8%) respectively). Finally they 
found no significant correlations between any 
of the hemodynamic variables measured. 
In another study [106], 12 normal 
subjects and 18 diabetic patients with 
background retinopathy were used for taking 
measurements of the total retinal volumetric 
blood flow and venous diameter in a similar 
way as the above mentioned experiment, using 
the same hemodynamic parameters. They 
found a positive linear correlation between the 
venous diameter measurements and the 
maximum erythrocyte velocity using a 
bidirectional laser Doppler in four to five 
major retinal veins both in normal subjects and 
diabetic patients. The results showed a 
significantly larger blood flow and venous 
cross section in the diabetic patients than 
normal subjects (p-value=0.02 and p-
value=0.001 respectively). Blood flow was 
found significantly larger in temporal retina 
than in nasal retina in normal subjects (p-
value=0.0008) and diabetic patients (p-
value=0.0002). The measured blood flow was 
also significantly different between the 
superior and inferior retina in diabetic patients 
(p-value=0.03) but not in normal subjects. 
Bursell et al. conducted a comprehensive 
experiment investigating the retinal blood flow 
changes in patients with type 1 diabetes and 
age-matched normal subjects [107]. It was also 
investigated whether blood glucose levels can 
alter the retinal blood flow and whether this 
can influence blood flow data in cross-
sectional studies. Fluorescein angiography was 
used and blood glucose levels were adjusted in 
3 levels using a glucose clamp in order to 
achieve values at 100, 200 and 300 mg/dl, 
taking blood flow measurement in each of 
these levels. Retinal blood flow was found to 
Figure 1. Blood flow velocity correlation with the mean 
arterial pressure using Retinal Function Imager [68]. 
be significantly decreased in diabetic patients 
(19.4±4.6 arbitrary units, p-value<0.01) in 
comparison with the blood flow in normal 
subjects (28.7±6.4 arbitrary units). During the 
glucose clamp in diabetic patients the retinal 
blood flow increased at the 200 mg/dl and to 
300 mg/dl (21.5±4.7 arbitrary units, p-
value<0.05 and 25.9±8.8 arbitrary units, p-
value<0.01 respectively) in comparison with 
the 100mg/dl level (16.3±3.8 arbitrary units). 
In addition to the blood flow they took 
measurements of arterial and venous diameters 
but the results presented no significant 
differences in all the glucose clamps and 
between the two groups. 
The rate of retinal blood flow depends 
on several factors, which determine the 
perfusion pressure and the vascular resistance. 
Perfusion pressure is the pressure that drives 
the blood into the retinal vasculature. Vascular 
resistance is generated by the combination of 
the retinal vessels and the blood viscosity [63]. 
Blood flow rate (Q) using the LDV 
method has been found to vary with D2.76±0.16 
in the arteries (values of diameter (D) between 
39 and 145µm) and D2.84±0.12 for the veins 
(values of D between 64 and 177µm) [108]. 
These values are in close agreement with 
Murray’s law [109], which calculates an 
exponent value of 3 for a vascular system that 
seeks an optimum compromise between blood 
volume and vascular resistance or in other 
words that minimizes its resistance for a given 
volume. Feke et al found an exponent of 4.1 
for D>100µm [110] and Garcia et al a 3.35 for 
D between 84-177µm [111]. In another study 
using dye delivery technique found an 
exponent of 2.9 for retinal arterioles and 
arteries with a D between 20 and 80µm [112]. 
In literature, as far as normal subjects are 
concerned, the values of the blood flow rate 
between studies varies between 30 and 38 
µl/min [106, 108] and from 65-80 µl/min (102, 
110, 111). These differences in measurements 
are attributed to the fact of different 
methodological approaches.  
As outlined by Burgansky, the 
correlation of blood flow velocity to 
physiological parameters is very important in 
order to understand the effects that diabetes 
can have to the human body functionality. In 
figure 1 it is shown that for healthy group the 
flow velocity in arterioles is positively 
correlated with mean arterial pressure (r=0.29, 
p-value=0.006). For the systolic blood 
pressure the correlation coefficient r=0.3 the p-
value=0.04 and for the diastolic blood pressure 
the values are for r=0.4 and p-value=0.009) 
[68].The interesting part in this is that there 
was no significant correlation observed 
between blood flow velocity and mean arterial 
pressure in both pre-retinopathy and diabetic 
retinopathy patients. This indication does not 
exclude the fact that there might be reduced 
correlation since it could be impaired by other 
factors while diabetes develops and 
progresses. 
 The average heart rate influence in the 
average velocity was also investigated but no 
statistically significant correlation was found 
in either healthy, diabetic or DR subjects. The 
relationship was assessed by correlating the 
heart rate and velocity measurements recorded 
simultaneously (figure 2). 
In a very recent comprehensive study [66], 
type 1 diabetic patients aged 12-20 years were 
used including clinical assessment and retinal 
photography. A total number of 1.159 patients 
were recruited from which the 944 of them had 
gradable photographs and 170 of them had 
retinopathy. The following geometric features 
were evaluated: branching angles, arteriolar 
and venular tortuosity, optimality deviation 
and length-to-diameter ratio from digitized 
photographs. In addition, their efforts focused 
as well on the association of the geometric 
Figure 2. Retinal blood flow-velocity and heart rate 
correlation of all the data used. A. Healthy group, B. 
Diabetes group, C. DR group [68]. 
characteristics with diabetes duration, A1C 
haemoglobin level and systolic blood pressure. 
An association between the older age and 
decreased arteriolar (p-value=0.024) and 
venular tortuosity (p-value=0.002) was found. 
Another interesting finding was that female 
subjects had larger arteriolar branching angle 
than male (p-value=0.03). Moreover longer 
duration of diabetes was associated with larger 
arteriolar branching angle (p-value<0.001) as 
well as with increased arteriolar optimality 
deviation (p-value=0.018). Increased level of 
A1C haemoglobin was associated with 
increased arterial tortuosity (>8.5% vs. 
<=8.5%, p-value=0.008). Length-to-diameter 
ration was associated with higher systolic 
blood pressure (p-value=0.002) and increased 
arteriolar length-to-diameter ration was 
associated with higher total cholesterol levels 
(p-value=0.044) and decreased venular 
optimality deviation (p-value=0.044). It is also 
mentioned that these associations remain even 
after controlling A1C, retinal vessel calibre 
and retinopathy status and was observed in 
non-retinopathy subjects as well. 
Unfortunately, when it comes to review, 
compare and summarize such studies some 
problems arise that make the interpretation a 
bit problematic. Most of the studies do not use 
the same techniques for measurements and 
they do not have the same requirements for 
selecting participants. The results cannot be 
compared when the groups of participants 
have different demographic background and/or 
different medical record (other diseases etc.). 
On the other hand these results give us a good 
indication on what is happening in the retina 
from many different perspectives both from 
the hemodynamic and geometric side. This can 
help us move forward and plan future studies, 
which will be based on the previous findings, 
trying at the same time to increase the factors 
that are taken into account in order to enhance 
the robustness and reliability of the analysis 
and the results. 
 
Oxygen perfusion 
It is still uncertain and unclear the exact 
cause of the elevated oxygen saturation in DR 
but it is evident that normal response of the 
retinal circulation in preventing hyper-
oxygenation is impaired by hyperglycaemia 
[65]. 
Oxygen distribution is another major 
factor in the vessel wall oxygen perfusion. The 
process of the oxygen distribution can be 
affected by some factors including capillary 
non-perfusion and shunting, thickening of 
capillary basement membranes and oxygen 
affinity of haemoglobin in diabetic patient 
[102].  
If the capillary network is at some point 
shunted, the blood may bypass it through 
dilated channels. During this state some of the 
capillaries are closed and some dilated. Some 
studies using fluorescein angiography have 
shown that dilated capillaries force the blood 
to pass from arterioles to venules in the retina 
leading to capillary non-perfusion [113]. This 
“unhealthy” process makes the transport of 
blood faster than normal making the venules 
blood hyperoxic and the rest of the blood 
hypoxic in these non-perfused areas. The 
capillary non-perfusion in addition to shunting 
disturbs the normal blood flow altering the 
normal oxygenation that may lead to different 
pathologies. As a consequence the non-
perfused areas do not extract the oxygen from 
the haemoglobin, so these venules have higher 
oxygenation levels making this tissue hypoxic 
and thus ischemic. 
One of the observations during DR is 
that capillary walls thicken which can lower 
oxygen delivery levels. It is assumed that in 
this situation the oxygen is inhibited from the 
efficiently diffusing and perfusing vessels 
contributing probably to the elevated 
oxygenation of the blood. Knowing the high 
importance of the oxygen for the functionality 
and preservation of tissues it can be inferred 
that the mal-distribution during the disease 
state makes the tissue hypoxic, elevating the 
demands of oxygen thus increasing the blood 
flow to deliver more oxygen. The above way is 
one reason that total blood flow can be 
increased in DR [113]. 
It is easily understood that dead tissue 
cannot consume oxygen. Tissue degeneration 
lowers the total amount of oxygen extracted by 
blood vessels increasing simultaneously the 
venous oxygen saturation as mentioned in 
[114]. 
It is speculated that the affected 
microcirculation in diabetes has an effect on 
retinal vessel saturation [115]. Pathogenesis in 
diabetic retinopathy has been linked to retinal 
hypoxia, which triggers neovascularization and 
retinal oedema [116]. 
Bahram et al. conducted a 
comprehensive experiment in order to 
determine the retinal oxygen saturation trend 
with onset of diabetes and increasing severity 
of DR by comparing diabetic groups with and 
without retinopathy [114]. For this purpose 
they used a fundus camera-based dual 
wavelength snapshot oximeter to take images 
of the retina for the whole recruited group and 
analyse them to determine oxygen saturation 
in the major arteries and veins. It was found 
that in normal subjects the saturation in 
arteries was 92.3±4.2% and in veins 57.2±6%, 
in diabetic patients without DR was in arteries 
96.3±8.6% and in veins 58.7±7.5%, in diabetic 
patients with mild to moderate non 
proliferative DR in arteries it was 97.7±5.8% 
and in veins 61.1±7.6%. The saturation for 
diabetics with severe non-proliferative DR was 
in arteries 102±10.2% and in veins 66.8±8.4%. 
In patients with proliferative DR in arteries 
was 103.6±8.7% and in veins 66.6±10.2% and 
finally in all diabetics with DR combined in 
arteries was 100.4±7.6% and in veins 
64.2±8.4%. From this study it is clear that 
there is a trend of increasing the retinal oxygen 
saturation from healthy subjects to non-
diabetic retinopathy group and to diabetic 
retinopathy patients. 
During DR the oxygen perfusion might 
be influenced by the impaired blood flow. In 
Jorgensen et al., 156 diabetic patients, 48 with 
type 1 and 108 with type 2 diabetes were 
recruited, in addition to 80 age-matched 
normal subjects [117]. For the normal controls 
any other diseases like ocular diseases, 
diabetes or hypertension were excluded. They 
used a retinal oximetry device in order to 
measure the oxygen saturation in veins and 
arteries. As observed in proliferative DR 
patients the arterial saturation was significantly 
higher than normal subjects and in diabetic 
patients with retinopathy not requiring 
treatment, whereas there was no significant 
difference with diabetic patients without 
retinopathy. 
Regarding the veins, the diabetic patients 
with or without retinopathy presented 
significantly higher saturation than normal 
subjects. Another important observation shows 
that the oxygen extraction decreases with 
increasing severity of retinopathy, namely 




Unfortunately, despite the great deal of 
research that is being conducted for detecting 
and diagnosing DR in an early stage before the 
first lesions appear, still remains unclear how 
the biochemical alterations in the human body 
during the development and progress of 
diabetes affect the retinal vessel structure and 
the hemodynamic functionality. The exact 
mechanisms and the sequence of them that 
lead to the appearance of the first lesions, like 
micro-aneurysms or hemorrhages are still not 
very well understood. Because of that it is very 
difficult to evaluate the vasculature structure 
of a diabetic patient, monitor the changes that 
occur and then associate them with the 
progress and effect of diabetes. There is still 
no biomarker that can satisfy the criteria of 
reliability, accuracy and generalization with 
defined limitations, let alone when it comes to 
take into account some risk factors like age, 
gender, duration of diabetes, other diseases etc. 
A definite and robust connection between the 
hemodynamic features (blood flow volume 
rate, blood flow velocity, oxygen perfusion, 
circulation time, vessel wall stiffness, body 
functionality etc.) and the geometric features 
(vessel width, tortuosity index, wall thickness 
etc.) is needed. This would help us understand 
how a change in the hemodynamic 
functionality, which will only be correlated 
with diabetes, is depicted in the vasculature 
both qualitatively and quantitatively. Having 
such a direct connection with concrete features 
and specific conditions could give us a 
biomarker, reliable enough to use it as a 
predictor of early progression or inherent 




As mentioned previously, quite a lot of 
ongoing studies investigate the possibility of 
early screening of DR. Even in the very recent 
literature, there is no definite and reliable 
connection of the changes in the retinal 
vasculature and the development of DR. Until 
recently, it was impossible to take oxygen 
saturation measurements in the vessel 
segments accurately and reliably. In the last 
years it has become possible to study the 
oxygen saturation in the retinal vasculature, 
taking accurate measurements and at the same 
time investigate whether oxygen perfusion 
impairment precedes or follows the 
development of DR. According to the wider 
trends, as well as the research activity in our 
research group, the next five years will be 
quite important in understanding the effect of 
diabetes in the retinal vasculature. Oxygen 
perfusion seems to play a crucial and quite 
distinctive role in all the stages of DR both in 
normal and diabetic subjects. It remains to 
have a direct correlation with some risk factors 
like age, gender, type of diabetes etc. and even 
more important to exclude any other diseases. 
This is crucial since it will validate that 
diabetes or DR only affects the measured 
features. A great challenge and another 
important observation is the auto-regulatory 
responses of the retinal vasculature to the 
altered hemodynamic function, which is yet 
unclear the way it is impaired in connection 
with the disease. Furthermore there might be 
some progress in understanding whether the 
final positions of the lesions in the vasculature 
are random or if they are determined by other 
factors and whether any changes to the 
vessels’ position occur before the lesions 
finally appear in this specific area. 
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• Diabetic	  retinopathy	  is	  a	  major	  cause	  of	  blindness.	  
• There	  is	  no	  reliable	  biomarker	  yet	  that	  can	  predict	  or	  diagnose	  DR.	  
• Diabetes	  causes	  many	  changes	  to	  the	  body	  functionality	  that	  lead	  to	  DR.	  
• Oxygen	  saturation	  level	  in	  the	  veins	  and	  arteries	  is	  different	  between	  normal	  subjects,	  diabetic	  patients	  and	  DR	  patients.	  
• Endothelial	  cells’	  function	  is	  severely	  altered	  during	  diabetes,	  which	  is	  a	  major	  complication	  that	  can	  lead	  to	  DR.	  
• Blood	  flow	  and	  vessel	  structure	  is	  highly	  affected	  during	  the	  development	  and	  progress	  of	  diabetes.	  
• Risk	  factors	  like	  age,	  gender,	  duration	  of	  diabetes,	  other	  diseases,	  family	  history	  etc.	  are	  important	  parameters	  that	  have	  to	  be	  considered	  when	  studying	  the	  progress	  of	  diabetes.	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